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Human T-cell leukemia virus type 1 (HTLV-1) is an
oncogenic retrovirus etiologically causal of adult T-cell
leukemia (ATL). ATL is a highly virulent cancer that is
resistant to chemotherapeutic treatments. To under-
stand this disease better, it is important to compre-
hend how HTLV-1 promotes cellular growth and
survival. The human T-cell leukemia virus type 1
(HTLV-1) basic leucine zipper factor (HBZ) gene is
encoded by the minus strand of the HTLV-1 provirus
and transcribed from the 3’ long terminal repeat
(LTR). HBZ expression promotes proliferation and sur-
vival of HTLV-1 infected cells in vivo. Although pre-
vious reports have been aimed at understanding the
potential role of HBZ in HTLV-1 pathogenesis, little is
known as to how this viral gene is regulated in ATL
cells. Here using our K30-3’asLuc reporter construct,
we show that HBZ protein upregulates antisense tran-
scription. Generation of stable clones in 293T cells
confirm that HBZ stimulates antisense transcription
from the 3’ LTR through its interaction with JunD, an
AP-1 protein, and its action on the Sp1 binding site
located in the 3’LTR. Our results suggest that in vivo
inhibition of JunD could be a possible new therapeutic
strategy in ATL treatment.
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